4/2
11:50 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
High
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
4/2
11:50 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
High
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $12.00 price target on the stock.
4/2
11:35 am
cmpx
Rating for CMPX
High
Report
Rating for CMPX
4/2
11:35 am
cmpx
Rating for CMPX
High
Report
Rating for CMPX
4/2
08:11 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $6.00 price target on the stock, up previously from $4.00.
High
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $6.00 price target on the stock, up previously from $4.00.
4/2
08:02 am
cmpx
Rating for CMPX
High
Report
Rating for CMPX
4/2
06:17 am
cmpx
Compass Therapeutics upgraded to Outperform from Market Perform at Leerink
High
Report
Compass Therapeutics upgraded to Outperform from Market Perform at Leerink
4/1
10:31 pm
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
High
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
4/1
10:31 pm
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
High
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
2/24
09:40 am
cmpx
Rating for CMPX
Medium
Report
Rating for CMPX
2/24
09:40 am
cmpx
Rating for CMPX
Medium
Report
Rating for CMPX
2/24
07:07 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
Low
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
2/24
07:07 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
Low
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
2/24
06:32 am
cmpx
Compass Therapeutics initiated with a Buy at Guggenheim
Low
Report
Compass Therapeutics initiated with a Buy at Guggenheim
2/24
06:32 am
cmpx
Compass Therapeutics initiated with a Buy at Guggenheim
Low
Report
Compass Therapeutics initiated with a Buy at Guggenheim
2/10
04:26 pm
cmpx
Rating for CMPX
Medium
Report
Rating for CMPX
2/10
04:26 pm
cmpx
Rating for CMPX
Medium
Report
Rating for CMPX